Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

RadNet, Inc. - Common Stock (NQ:RDNT)

52.51 +1.89 (+3.73%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about RadNet, Inc. - Common Stock

< Previous 1 2 3 4 Next >
What 4 Analyst Ratings Have To Say About RadNet
Via Benzinga
Cramer Calls Datadog 'Dynamite,' Puts SoFi In Dog House: 'What The Heck Is Going On'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Marvell Technology, Inc. (NASDAQ: MRVL) reported a mixed quarter. 
Via Benzinga
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance. 
Via Benzinga
Earnings Outlook For RadNet
Via Benzinga
A Preview Of RadNet's Earnings
Via Benzinga
RadNet Forecasts Lower Profits In 2022 Due To Rising Costs, Labor Shortage
Via Benzinga
AerSale Posts Downbeat Results, Joins Costco, MongoDB And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling by around 30 points on Friday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results. 
Via Benzinga
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Cramer's Top Auto Pick After 'Very Big Spike': 'By Far The Best Of The Group'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Weyerhaeuser Company’s (NYSE: WY) stock long term. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2023
Via Benzinga
Jim Cramer Says This Major Telecom Stock Is 'Horrendous'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he actually likes Acushnet Holdings Corp. (NYSE: GOLF), adding that his pal told him that "gold is hot." 
Via Benzinga
3 Super Speculative AI Stocks Not Worth the Risk
You're deluding yourself if you believe these three potential AI stocks are sure bets. They're not worth the risk. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Biotech & Healthcare Meet AI: Stocks Soar On Innovation Potential
A growing number of companies in the biotech and healthcare industries are using AI to revolutionize drug discovery and patient care, leading to stock surges. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Jim Cramer Says 'Hats Off To Jamie Dimon': Why He's Bullish On JPMorgan
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he still likes JPMorgan Chase & Co. (NYSE: JPM) here, adding that "it’s valued very low given the fact that it is a colossus. 
Via Benzinga
United Airlines To Rally Around 37%? Here Are 10 Other Analyst Forecasts For Monday
Raymond James boosted the price target for RadNet, Inc. (NASDAQ: RDNT) from $35 to $40. Raymond James analyst John Ransom maintained an Outperform rating. RadNet shares rose 2.1% to close at $33.44 on... 
Via Benzinga
Jim Cramer Deems This 5% Yield Stock 'Too Risky For Me': He Prefers These 2 Alternatives
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Dominion Energy, Inc. 
Via Benzinga
Why RadNet (RDNT) Stock Is Getting Hammered
RadNet Inc (NASDAQ: RDNT) shares are trading lower by 8.71% to $30.12 Wednesday afternoon after the company announced the pricing of its underwritten public offering of 7.575 million shares for $29.75... 
Via Benzinga
MicroVision, RadNet And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session. MicroVision, Inc. (NASDAQ: MVIS) shares dropped 12.7% to $5.56 in... 
Via Benzinga
Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers WeTrade Group, Inc. (NASDAQ: WETG) shares climbed 140.3% to $20.28. WeTrade launched large-scale language processing models to increase product applications in the field of artificial... 
Via Benzinga
Lennar, RadNet And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Chart Of The Day: RadNet - Analysts Look For 17%+ Gains
RadNet Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
Via Benzinga
Analyst Upgrades This Radiology Stock, Expects Promising 2023 Ahead
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2023
Via Benzinga
Earnings Scheduled For February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter. 
Via Benzinga
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 283 companies set new 52-week lows. 
Via Benzinga
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session
Gainers 
Via Benzinga
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.